Sales Associate, Cambrium
+ Employee Stock Options
Engineering high-performance proteins
Job no longer available
Engineering high-performance proteins
21-100 employees
Job no longer available
+ Employee Stock Options
21-100 employees
Company mission
To trigger the next wave of material innovation by harnessing biology's molecular building blocks.
Jump to section
Company mission
To trigger the next wave of material innovation by harnessing biology's molecular building blocks.
Our take
Animal-derived collagen has long been a staple in personal care, fashion, and other applications, but it comes with environmental and ethical concerns. Cambrium is stepping in with a sustainable alternative, leveraging cutting-edge technologies to design, scale, and manufacture novel molecular building blocks for man-made collagen.
Having secured funding and partnerships, Cambrium aims to transition the early successes of its skin-identical collagen ingredient NovaColl into a lasting impact, by scaling its manufacturing and commercial activities for animal-free collagen products.
Its technology not only presents a viable solution to reduce reliance on animal-derived collagen, but accelerates the development of other innovative biomolecules, suggesting a future where Cambrium could create high-performance, sustainable materials for various other sectors.
Freddie
Company Specialist at Welcome to the Jungle
Funding (1 round)
Oct 2023
$9.3m
SEED
Total funding: $9.3m
Leadership
Mitchell Duffy
(Co-Founder & CEO)Graduated from the University of Münster with a PhD in Molecular Imaging.
Charlie Cotton
(Co-Founder & CSO)Graduated from the Imperial College London with a PhD in Structural and Synthetic Biology.